Media Thread, page-11525

Thanks for posting this, SP.

I'm short of time so I won't try and do exact quote, but a few thing stood out for me:

• Leslie confirmed that some of the patients from the initial Phase1B Her-vaxx + Chemo trial are still alive, 3 or 4 years down the track. This is something several of us here have speculated about, but the last update we had was the presentation at the ESMO world congress in June last year. To have some of the Her-vaxx patients from that study still alive after this length of time is impressive.
• Interesting to hear her list some of the cancers in which they are seeing Vaxinia have an effect. Testicular Cancer gets a mention. Presumably this is the Testicular Mesothelioma patients previously mentioned by Yuman Fong. The cancers she specifically names are "Bile Duct, Melanoma, Testicular Cancer, Breast Cancer, NSC Lung Cancer."
• With regard to Vaxinia LC states that "I see a real path for future approvals, but I see an even a .. a just a delightful path where we could partner with big Pharma, so that we can get this out there sooner, faster for patients. She mentions partnership a second time, though also says they could top right through to registration alone if they have to.

Cheers

Dave